Teva Pharmaceutical Industries (TEVA): Director sold ~$6.29M

~$6.29M

Approx. value · 286K sh @ $22.01

695K

Holds after · shares reported

Traded

Dec 20, 2024

Filed

Dec 26, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 20, 2024InsiderOfficer sold ~$327K of TEVA shares in the open market
2. Dec 20, 2024 · this disclosureInsiderDirector sold ~$6.29M of TEVA shares in the open market

What came next

1. Feb 12, 2025InsiderOfficer sold ~$2.89M of TEVA shares in the open market
2. Feb 18, 2025InsiderCEO sold ~$1.28M of TEVA shares in the open market
3. Feb 28, 2025InsiderCFO sold ~$903K of TEVA shares in the open market
4. Mar 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.5M)
5. Mar 4, 2025Insider · 5 peopleInsiders: 10 sales (~$2.4M)
6. Mar 5, 2025Insider · 5 peopleInsiders: 9 sales (~$2.2M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Teva Pharmaceutical Industries

For Teva Pharmaceutical Industries, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TEVA page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Teva Pharmaceutical Industries

• SEC Form 144Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026

Everything OQRO holds on this company is on its TEVA page.